Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction

Journal of Hepatology

Volumn 24, Issue 3, 1996, Pages 258-264

  Inokuchi, Kaoru ^a   Nakata, Keisuke ^a   Hamasaki, Keisuke ^a   Daikoku, Manabu ^a   Nakao, Kazuhiko ^a   Kato, Yuji ^a   Yatsuhashi, Hiroshi ^b   Koga, Michiaki ^b   Yano, Michitami ^b   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagasaki Chuo National Hospital   (Japan)

Author keywords

fulminant hepatitis; hepatitis B virus; hepatitis C virus; polymerase chain reaction

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; VIRUS GENOME; VIRUS HEPATITIS;

EID: 0029916770     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80002-X     Document Type: Article

References (32)

1. O'Grady J, Schalman SW, Williams R. Acute liver failure: redefining the syndrome. Lancet 1993; 324: 273-5.
2. Lee WR. Acute liver failure. N Engl J Med 1993; 329: 1862-72.
3. Ishiguro N, Tomimatsu M, Nagahara H, Obata H. Clinical evaluation of a newly established anti-HCV assay for the diagnosis of hepatitis C in Japan. Gastroenterol Hepatol 1992; 7: 602-7.
4. DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagel JH, Melpolder JJJ, Alter HJ. Long- term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969-74.
5. Jeffers LJ, Hasan F, DeMedina M, Reddy R, Parker T, Silvia M, Mendez L. Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology 1992; 15: 187-90.
6. Kaneko S, Miller R, Feinstone S, Unoura M, Kobayashi K, Hattori N, Purcell R. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis utilizing the polymerase chain reaction assay. Proc Natl Acad Sci, USA 1988; 86: 312-6.
7. Troy C, Davison CJ. The management of fulminant hepatic failure. In: Popper H, Schaffer F, eds. Prognosis in Liver Diseases, Vol III. New York: Grune & Stratton, 1970: 282-98.
8. Kaneko S, Feinston SM, Miller RH. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol 1989; 27: 1930-3.
9. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5́-noncoding region. Jpn Exp Med 1990; 60: 215-22.
10. Chao YC, Lee CM, Tang HS, Govindrajan S, Lai MMC. Molecular cloning and characterization of hepatitis D virus from Taiwan. Hepatology 1991; 13: 345-52.
11. Carman WF, Jacyna MR, Hadziyannis S. Mutation preventing formation of hepatitis B e antigen in patient with chronic hepatitis B infection. Lancet 1989; ii: 588-91.
12. Okamoto H, Yotsumoto S, Akahane Y, Miyazaki Y, Sugai Y, Tsuda F. Hepatitis B virus with precore region defect prevail in persistently infected hosts along with sero-conversion to the antibody against e antigen. J Virol 1990; 64: 1298-303.
13. Hamasaki K, Nakata K, Nagayama Y, Ohtsuru A, Daikoku M, Taniguchi K, Tsusumi T, Nagataki S. Changes in prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B. Hepatology 1994; 20: 8-14.
14. Takahashi Y. Acute hepatic failure: in special relation to treatment. Jpn J Med 1983; 22: 140-5.
15. Takahashi Y, Shimizu M. Study group of fulminant hepatitis. Etiology and prognosis of fulminant viral hepatitis in Japan: multicenter study. J Gastroenterol Hepatol 1991; 6: 159-64.
16. Hamasaki K, Nakata K, Tsutsumi T, Turuta S, Nakao K, Kato Y, Shima M, Nagataki S. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan. J Med Virol 1993; 40: 146-9.
17. Romeo JM, Ulich PP, Busch MP, Vyas GN. Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors. Hepatology 1993; 17: 188-95
18. Boudart D, Lucas JC, Adjou C, Muller JY. HCV confirmatory testing of blood donors. Lancet 1992; 339: 372.
19. Allain JP, Rankin A, Kuhns MC, McNamara A. Clinical importance of HCV confirmatory testing in blood donors. Lancet 1992; 339: 1171-2.
20. Yanagi M, Kaneko S, Unoura M, Murakami s, Kobayashi K, Sugihara J, Ohnishi H, Muto Y. Hepatitis C virus in fulminant hepatic failure. N Engl J Med 1990; 324: 1895-6.
21. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrel L, Lake J, Roberts J, Ascher NL. Hepatitis B virus and apparent fulminant non-A non-B hepatitis. Lancet 1992; 339: 952-5.
22. Matsuo A, Kusumoto Y, Ohtsuka E, Nakamura Y, Tajima H, Shima M, Nakata K, Muro T, Satoh A, Ishii N, Koji T, Nagataki S. Changes in HBsAg carrier rate in Goto Islands, Nagasaki Prefecture, Japan. Lancet 1990; 335: 955-7.
23. Hasegawa K, Huang J, Wands JR, Obatta H, Liang TJ. Association of hepatitis B virus precore mutations with fulminant hepatitis B in Japan. Virology 1991; 185: 460-3.
24. Carman WF, Fagan EA, Hadziyannis S, Karayiannis P, Tossopolos NC, Wiliams R, Thomas HC. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 1991; 14: 219-22.
25. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324: 1705-9.
26. Kosaka Y, Takase K, Kojima M, Simizu M, Inoue K, Yoshiba M, Tanaka S, Akahane Y, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastoroenterology 1991; 100: 1087-94.
27. Lukus T, Persing DH, Nowichi MJ, Mosley JW. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993; 105: 1173-8.
28. Ehata T, Omata M, Chuang WL, Yokosuka O, Itho Y, Itho K, Ohto M. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant hepatitis. J Clin Invest 1993; 91: 1206-13.
29. Millich DR, Jones JE, Hughes JL, Price J, Raney AK, Mclachlan A. Is the function of secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990; 87: 6599-603.
30. Massale G, Redeker A, Person J, Fowler P, Guilhot S, Schilichit HJ, Ferrari C. HLA-A3 I - and HLA-Aw68-restricted cytotoxic T cell responses to single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 1993; 177: 751-62.
31. Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yonomura K, Tsuda F, Tanaka T, Okamoto H, Miyakawa Y, Mayumi M. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122: 242-48.
32. Lau JY, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 1335-39.